Levaquin: FDA fails to disclose additional serious side effects of antibiotic linked to deaths

In Autoimmune Disease, Cancer, Chronic Illness by SFSCTCAdminLeave a Comment

Calls for updated label warnings

The U.S. Food & Drug Administration is failing to disclose additional serious side effects associated with one of the most popular and widely used prescription drugs on the market. The drugs are part of a family of antibiotics collectively known as fluoroquinolones and are marketed under brand names including Levaquin, Cipro and the generic form Levofloxacin.
READ MORE

Leave a Comment